Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,111 | 50 | 68.6% |
| Consulting Fee | $900.00 | 1 | 29.2% |
| Travel and Lodging | $39.81 | 2 | 1.3% |
| Education | $27.27 | 1 | 0.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Neptune Medical Inc. | $900.00 | 1 | $0 (2023) |
| Medtronic, Inc. | $646.28 | 7 | $0 (2024) |
| ABBVIE INC. | $500.48 | 15 | $0 (2024) |
| Janssen Biotech, Inc. | $191.71 | 7 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $144.76 | 5 | $0 (2024) |
| RedHill Biopharma Inc. | $124.55 | 1 | $0 (2021) |
| Lilly USA, LLC | $118.96 | 4 | $0 (2024) |
| COVIDIEN LP | $113.44 | 1 | $0 (2018) |
| Celltrion USA Inc. | $71.03 | 3 | $0 (2024) |
| Phathom Pharmaceuticals, Inc. | $50.04 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,424 | 40 | Medtronic, Inc. ($491.98) |
| 2023 | $1,065 | 3 | Neptune Medical Inc. ($900.00) |
| 2022 | $128.61 | 6 | ABBVIE INC. ($81.59) |
| 2021 | $304.87 | 3 | Medtronic, Inc. ($154.30) |
| 2018 | $155.26 | 2 | COVIDIEN LP ($113.44) |
All Payment Transactions
54 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $25.94 | General |
| Category: INTERNAL MEDICINE | ||||||
| 12/17/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $29.30 | General |
| Category: IMMUNOLOGY | ||||||
| 12/11/2024 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $22.71 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 12/06/2024 | Celltrion USA Inc. | VEGZELMA (Biological) | Food and Beverage | In-kind items and services | $24.38 | General |
| Category: ONCOLOGY | ||||||
| 12/04/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $23.68 | General |
| Category: Gastroenterology | ||||||
| 11/19/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $25.71 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/15/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $29.66 | General |
| Category: Immunology | ||||||
| 11/11/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $24.58 | General |
| Category: Immunology | ||||||
| 11/05/2024 | Medtronic, Inc. | GI GENIUS (Device) | Food and Beverage | In-kind items and services | $46.37 | General |
| Category: Gastrointestinal AI | ||||||
| 11/01/2024 | Celltrion USA Inc. | VEGZELMA (Biological) | Food and Beverage | In-kind items and services | $19.38 | General |
| Category: ONCOLOGY | ||||||
| 10/29/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $29.93 | General |
| Category: Immunology | ||||||
| 10/28/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $18.09 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/18/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $27.77 | General |
| Category: Immunology | ||||||
| 10/14/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $16.28 | General |
| Category: Neuroscience | ||||||
| 10/01/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $44.69 | General |
| Category: Immunology | ||||||
| 07/12/2024 | ABBVIE INC. | LINZESS (Drug), CREON, VIBERZI | Food and Beverage | In-kind items and services | $27.51 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/07/2024 | Ferring Pharmaceuticals Inc. | REBYOTA (Biological) | Food and Beverage | In-kind items and services | $25.38 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/07/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $22.85 | General |
| Category: Gastroenterology | ||||||
| 04/05/2024 | ABBVIE INC. | RINVOQ (Biological), HUMIRA | Food and Beverage | In-kind items and services | $24.57 | General |
| Category: IMMUNOLOGY | ||||||
| 04/03/2024 | Celltrion USA Inc. | ZYMFENTRA (Biological) | Education | In-kind items and services | $27.27 | General |
| Category: GASTROENTEROLOGY | ||||||
| 03/28/2024 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $195.97 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 03/16/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $36.63 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 03/14/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $22.19 | General |
| Category: Immunology | ||||||
| 03/14/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $3.00 | General |
| Category: Immunology | ||||||
| 03/11/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $41.67 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 43 | 43 | $20,367 | $6,390 |
| 2022 | 11 | 442 | 592 | $553,991 | $72,509 |
| 2021 | 12 | 416 | 579 | $479,630 | $70,406 |
| 2020 | 2 | 30 | 31 | $13,885 | $3,819 |
All Medicare Procedures & Services
28 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 21 | 21 | $10,269 | $3,422 | 33.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 11 | 11 | $6,094 | $1,740 | 28.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 11 | 11 | $4,004 | $1,228 | 30.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 60 | 94 | $44,650 | $14,823 | 33.2% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 61 | 143 | $51,194 | $12,844 | 25.1% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 47 | 48 | $134,504 | $10,680 | 7.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 67 | 92 | $32,476 | $8,659 | 26.7% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 45 | 50 | $34,500 | $8,383 | 24.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 23 | 23 | $15,410 | $4,417 | 28.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 24 | 24 | $12,912 | $3,701 | 28.7% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 40 | 41 | $75,481 | $3,074 | 4.1% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 44 | 45 | $112,322 | $2,754 | 2.5% |
| 91110 | Imaging of digestive tract done from the inside of the digestive tract | Facility | 2022 | 18 | 18 | $18,198 | $1,854 | 10.2% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 13 | 14 | $22,344 | $1,321 | 5.9% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 54 | 159 | $55,332 | $14,514 | 26.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 77 | 121 | $41,503 | $14,480 | 34.9% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 46 | 46 | $24,012 | $6,774 | 28.2% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 30 | 40 | $18,440 | $6,491 | 35.2% |
| 45385 | Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare | Facility | 2021 | 28 | 29 | $83,370 | $6,451 | 7.7% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 32 | 34 | $22,780 | $6,060 | 26.6% |
| 45380 | Biopsy of the large bowel using an endoscope (colonoscopy) | Facility | 2021 | 40 | 40 | $99,897 | $4,501 | 4.5% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 43 | 43 | $78,243 | $3,802 | 4.9% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 18 | 18 | $11,700 | $3,315 | 28.3% |
| 91110 | Imaging of digestive tract done from the inside of the digestive tract | Facility | 2021 | 20 | 21 | $19,698 | $2,443 | 12.4% |
| 43235 | Diagnostic examination of esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 15 | 15 | $23,940 | $1,452 | 6.1% |
About Dr. Benjamin Yip, MD
Dr. Benjamin Yip, MD is a Gastroenterology healthcare provider based in San Francisco, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/31/2014. The National Provider Identifier (NPI) number assigned to this provider is 1962820605.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Benjamin Yip, MD has received a total of $3,078 in payments from pharmaceutical and medical device companies, with $1,424 received in 2024. These payments were reported across 54 transactions from 16 companies. The most common payment nature is "Food and Beverage" ($2,111).
As a Medicare-enrolled provider, Yip has provided services to 931 Medicare beneficiaries, totaling 1,245 services with total Medicare billing of $153,124. Data is available for 4 years (2020–2023), covering 28 distinct procedure/service records.
Practice Information
- Specialty Gastroenterology
- Location San Francisco, CA
- Active Since 03/31/2014
- Last Updated 06/25/2020
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1962820605
Products in Payments
- ENDOFLIP (Device) $249.64
- SKYRIZI (Biological) $210.56
- INTERSTIM (Device) $195.97
- RINVOQ (Biological) $160.82
- EndoFlip (Device) $154.30
- ENTYVIO (Biological) $144.76
- Talicia (Drug) $124.55
- OMVOH (Drug) $118.96
- MANOMETRY (Device) $113.44
- TREMFYA (Drug) $98.93
- STELARA (Biological) $92.78
- HUMIRA (Biological) $77.51
- VOQUEZNA (Drug) $50.04
- XELJANZ (Drug) $49.80
- XIFAXAN (Drug) $46.53
- GI GENIUS (Device) $46.37
- VEGZELMA (Biological) $43.76
- Olympus EMR & ESD Devices (Device) $41.82
- DUPIXENT (Biological) $36.63
- LINZESS (Drug) $27.51
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in San Francisco
Dr. Kenneth Mcquaid, M.d, M.D
Gastroenterology — Payments: $138,098
Dr. Melvin Heyman, M.d, M.D
Gastroenterology — Payments: $116,934
Bruce Wang, M.d, M.D
Gastroenterology — Payments: $88,042
Mimi Lin, M.d, M.D
Gastroenterology — Payments: $69,442
Dr. Wolfgang Korn, Md, MD
Gastroenterology — Payments: $37,556
Mandana Khalili, Md, MD
Gastroenterology — Payments: $22,443